You are here: Home » News-CM » Companies » Results
Business Standard

Jenburkt Pharmaceuticals standalone net profit declines 3.31% in the September 2019 quarter

Capital Market 

Sales rise 6.88% to Rs 34.18 crore

Net profit of Jenburkt Pharmaceuticals declined 3.31% to Rs 5.55 crore in the quarter ended September 2019 as against Rs 5.74 crore during the previous quarter ended September 2018. Sales rose 6.88% to Rs 34.18 crore in the quarter ended September 2019 as against Rs 31.98 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales34.1831.98 7 OPM %21.7122.14 -PBDT8.097.89 3 PBT7.557.56 0 NP5.555.74 -3

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, November 06 2019. 10:10 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU